Contrast-induced Nephropathy
📧 Sign up to get email alerts when something new happens for Contrast-induced Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT) [Phase 3]
Phase 3 trial comparing oral versus intravenous hydration to prevent contrast-induced nephropathy in patients with renal insufficiency has c…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Contrast Nephropathy and Nitrates [Phase 4]
Phase 4 trial update on preventing contrast-induced nephropathy using nitrates; results completed with posted results.
-
CLINICAL_TRIALS withdrawal · 2019-10-04Clinical Trial Update: Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy [Phase 4]
Phase 4 trial comparing oral versus intravenous hydration to prevent contrast-induced nephropathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Effect of a Pre-interventional Diet on Renal Function After Administration of Contrast Agent in Patients at Risk [Phase 4]
Phase 4 trial evaluating whether a pre-interventional diet affects renal function after contrast administration in patients at risk.
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study [NA]
A completed clinical trial investigating volume dose reduction in CT arteriography for aortic conditions, with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy. [Phase 2]
Phase 2 clinical trial comparing carvedilol versus atorvastatin for prevention of contrast-induced nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)
PRECISE-ICU is a completed clinical trial that examined risk factors, prevention strategies, and outcomes for contrast-induced acute kidney …
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI) [Phase 2]
Phase 2 clinical trial evaluating allopurinol or febuxostat to prevent contrast-induced acute kidney injury.
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization [Phase 3]
Phase 3 clinical trial update examining vitamin E and N-acetylcysteine for preventing contrast-induced acute kidney injury after coronary ar…
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography [Phase 2]
Phase 2 trial assessing the effect of spironolactone on acute kidney injury in patients undergoing coronary angiography has been completed.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography [NA]
The clinical trial evaluating renal protection against contrast medium–induced nephropathy in high-risk patients undergoing coronary angiogr…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Remote Ischemic Preconditioning as a Method Against Subclinical Renal Injury and Contrast-induced Nephropathy [NA]
This clinical trial update confirms the completion of a study evaluating remote ischemic preconditioning as a strategy to prevent subclinica…
-
CLINICAL_TRIALS research · 2017-10-06Clinical Trial Update: A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective? [NA]
A Maastricht University Medical Center trial evaluating guidelines for preventing contrast-induced nephropathy and acute kidney injury, focu…
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Efficacy of Statins In Prevention of CIN [NA]
This clinical trial evaluated whether statins can prevent contrast-induced nephropathy; the study was terminated and results were posted.
-
CLINICAL_TRIALS research · 2017-08-30Clinical Trial Update: Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
Clinical trial assessing whether CHA2DS2-VASC score and the ratio of contrast volume to creatinine clearance can predict contrast-induced ne…
-
CLINICAL_TRIALS research · 2017-08-25Clinical Trial Update: Investigation of Relationship Between Contrast Nephropathy and Caval Index Measurement in Patients With Ileus in ED
A clinical trial update investigating the relationship between contrast-induced nephropathy and caval index measurement in patients with ile…
-
CLINICAL_TRIALS research · 2017-08-03Clinical Trial Update: Ischemic Preconditioning for Prevention of Contrast Nephropathy in The Emergency Department [NA]
A trial exploring whether ischemic preconditioning can prevent contrast-induced nephropathy in emergency department patients, sponsored by D…
-
CLINICAL_TRIALS research · 2017-05-24Clinical Trial Update: Red Blood Cell Distribution Width as a Marker of Contrast Induced Nephropathy in Patients With Coronary Intervention
This ClinicalTrials.gov entry provides an update on a study exploring whether red blood cell distribution width can serve as a biomarker for…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement [Phase 4]
Phase 4 clinical trial update evaluating strategies to prevent contrast-induced nephropathy after transcatheter aortic valve replacement.
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN [NA]
Completed AVERT trial evaluating whether reducing contrast media volume lowers the incidence of contrast-induced nephropathy; results were p…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV) [NA]
The PRESERV trial evaluating reduction and removal of contrast media in patients with chronic kidney disease was terminated; results were po…
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy [NA]
Clinical trial update on the efficacy of Vitamin D for treating contrast-induced nephropathy; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases
The CASABLANCA study (Catheter Sampled Blood Archive in Cardiovascular Diseases) has completed status in the clinical trials registry. It in…
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: IVUS Guidance to Reduce Contrast in Coronary Angioplasty [Phase 4]
Phase 4 trial evaluating intravascular ultrasound guidance to reduce contrast use during coronary angioplasty and its impact on contrast-rel…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia [Phase 4]
Phase 4 prospective study from Croatia evaluating the incidence of contrast-induced nephropathy and preventive strategies in patients expose…